Zander Therapeutics, Inc Contracts & Agreements
37 Contracts & Agreements
- Business Finance (10 contracts)
- Business Operations (1)
- Human Resources (5)
- Intellectual Property (1)
- Uncategorized (20)
- PROMISSORY NOTE $500,000 Dated February 15, 2019 (Filed With SEC on May 31, 2019)
- CONSULTING FEE AGREEMENT (Filed With SEC on May 31, 2019)
- AGREEMENT BY AND BETWEEN ZANDER THERAPEUTICS INC. AND JUDITH A VARNER (Filed With SEC on April 26, 2019)
- AGREEMENT BY AND BETWEEN ZANDER THERAPEUTICS INC. AND DAVID CHERESH (Filed With SEC on April 19, 2019)
- AGREEMENT BY AND BETWEEN ZANDER THERAPEUTICS, INC. AND HARRY LANDER (Filed With SEC on January 25, 2019)
- INTELLECTUAL PROPERTY LICENSE AGREEMENT (Filed With SEC on January 24, 2019)
- SUBLEASEAGREEMENT (Filed With SEC on November 20, 2018)
- CONVERTIBLE PROMISSORY NOTE (Filed With SEC on October 4, 2018)
- Employment Agreement Harry Lander (Filed With SEC on September 26, 2018)
- Employment Agreement Todd Caven (Filed With SEC on September 26, 2018)
- Purchase Agreement 500,000 Shares (Filed With SEC on September 26, 2018)
- Purchase Agreement 50,000 Shares (Filed With SEC on September 26, 2018)
- Consulting Agreement Joey Harrick (Filed With SEC on September 26, 2018)
- Employment Agreement David Koos (Filed With SEC on September 26, 2018)
- Purchase Agreement 100,000 Shares (Filed With SEC on September 26, 2018)
- Purchase Agreement 50,000 Shares (Filed With SEC on September 26, 2018)
- ENTEST GROUP, INC. AND ZANDER THERAPEUTICS,INC. AGREEMENT (Filed With SEC on July 10, 2018)
- SUBLEASEAGREEMENT (Filed With SEC on July 10, 2018)
- COLLABORATIONAND DEVELOPMENT Agreement (Filed With SEC on July 10, 2018)
- EMPLOYMENTAGREEMENT BETWEEN ZANDERTHERAPEUTICS, INC. AND DavidR. Koos (Filed With SEC on June 21, 2018)
- ADVISORYAGREEMENT (Filed With SEC on June 15, 2018)
- PRIVATEPLACEMENT AGENT AGREEMENT (Filed With SEC on June 15, 2018)
- ZanderTherapeutics Inc. 4700Spring Street, Suite 304 LaMesa, CA 91942 (Filed With SEC on March 20, 2018)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 20, 2018)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 20, 2018)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 20, 2018)
- December 2017 Amendment to Regen Agreement (Filed With SEC on January 16, 2018)
- Stock Purchase Agreement 900,000 shares common (Filed With SEC on January 16, 2018)
- AGREEMENTBY AND BETWEEN REGEN BIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC. (Filed With SEC on October 4, 2017)
- AGREEMENT BY AND BETWEEN REGENBIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC. Dated June 15, 2016 (Filed With SEC on October 4, 2017)
- AGREEMENT BY AND BETWEEN REGENBIOPHARMA, INC. AND ZANDER THERAPEUTICS, INC. Dated September 12, 2017 (Filed With SEC on October 4, 2017)
- AGREEMENTBY AND BETWEEN ZANDER THERAPEUTICS, INC. ("ZANDER") AND ENTEST BIOMEDICAL,INC.("ENTEST")dated February 28, 2017 ("Agreement'') (Filed With SEC on October 4, 2017)
- SECURITIESPURCHASE AGREEMENT (Filed With SEC on October 4, 2017)
- AGREEMENTBY AND BETWEEN ZANDER THERAPEUTICS, INC. AND THOMAS DONNELLY (Filed With SEC on October 4, 2017)
- AGREEMENTBY AND BETWEEN ZANDER THERAPEUTICS, INC. AND ROBIN GASSER (Filed With SEC on October 4, 2017)
- EMPLOYMENTAGREEMENT BETWEEN ZANDERTHERAPEUTICS, INC. AND HarryM. Lander, Ph.D., M.B.A. (Filed With SEC on October 4, 2017)
- EMPLOYMENTAGREEMENT BETWEEN ZANDERTHERAPEUTICS, INC. AND ToddS. Caven (Filed With SEC on October 4, 2017)
